Cameron A McLintock1,2, James McKelvie3, Zisis Gatzioufas3, Jessica J Wilson4, David C Stephensen4, Andrew J G Apel4,5. 1. Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia. cameronmclintock@hotmail.com. 2. Queen Victoria Hospital, Holtye Road, East Grinstead, RH19 3DZ, UK. cameronmclintock@hotmail.com. 3. Queen Victoria Hospital, Holtye Road, East Grinstead, RH19 3DZ, UK. 4. The Eye Health Centre, 87 Wickham Terrace, Brisbane, QLD, 4000, Australia. 5. Princess Alexandra Hospital, 199 Ipswich Road, Woolloongabba, Brisbane, QLD, 4102, Australia.
Abstract
PURPOSE: To evaluate rotational stability and visual and refractive outcomes of supplementary toric IOLs (Sulcoflex Toric 653T, Rayner Intraocular Lenses Ltd) for residual astigmatic refractive error in pseudophakic eyes. METHODS: A retrospective interventional case series was conducted in a single surgeon practice. Charts of patients who had Sulcoflex Toric supplementary IOLs inserted between June 2009 and September 2015 were reviewed. Outcomes were compared between eyes with and without prior corneal transplant. Patients with at least 3-months follow-up were included. RESULTS: In 51 eyes, mean UDVA improved from 20/86 to 20/43 (p = 0.002), though UDVA was better in eyes without corneal grafts (20/31) than eyes with (20/62). The proportion of eyes achieving 20/20 UDVA was 43%, 61% and 17% overall, in eyes with prior graft and in eyes with no prior graft, respectively. Sixty-four percentage achieved a spherical equivalent of within 0.5D of target (84% no graft, 34% prior graft). Fifty-three percentage of eyes achieved a cylinder of within 0.5D of target (no graft: 73%, prior graft: 0%). Mean lens rotation was 8.23° on day 1, and mean maximal rotation during follow-up was 17.63°. Sixty-two percentage of IOLs required repositioning. Of those that required repositioning, this was conducted a mean of 2.3 times. The mean final IOL rotation (following repositioning if required) was 6.17°. CONCLUSION: Sulcoflex Toric supplementary IOLs result in good visual and refractive outcomes in eyes with no prior corneal graft. However, outcomes are sub-optimal in eyes with prior corneal transplantation, and the majority of lenses require repositioning.
PURPOSE: To evaluate rotational stability and visual and refractive outcomes of supplementary toric IOLs (Sulcoflex Toric 653T, Rayner Intraocular Lenses Ltd) for residual astigmatic refractive error in pseudophakic eyes. METHODS: A retrospective interventional case series was conducted in a single surgeon practice. Charts of patients who had Sulcoflex Toric supplementary IOLs inserted between June 2009 and September 2015 were reviewed. Outcomes were compared between eyes with and without prior corneal transplant. Patients with at least 3-months follow-up were included. RESULTS: In 51 eyes, mean UDVA improved from 20/86 to 20/43 (p = 0.002), though UDVA was better in eyes without corneal grafts (20/31) than eyes with (20/62). The proportion of eyes achieving 20/20 UDVA was 43%, 61% and 17% overall, in eyes with prior graft and in eyes with no prior graft, respectively. Sixty-four percentage achieved a spherical equivalent of within 0.5D of target (84% no graft, 34% prior graft). Fifty-three percentage of eyes achieved a cylinder of within 0.5D of target (no graft: 73%, prior graft: 0%). Mean lens rotation was 8.23° on day 1, and mean maximal rotation during follow-up was 17.63°. Sixty-two percentage of IOLs required repositioning. Of those that required repositioning, this was conducted a mean of 2.3 times. The mean final IOL rotation (following repositioning if required) was 6.17°. CONCLUSION: Sulcoflex Toric supplementary IOLs result in good visual and refractive outcomes in eyes with no prior corneal graft. However, outcomes are sub-optimal in eyes with prior corneal transplantation, and the majority of lenses require repositioning.
Authors: J L Gayton; D J Apple; Q Peng; N Visessook; V Sanders; L Werner; S K Pandey; M Escobar-Gomez; D S Hoddinott; M Van Der Karr Journal: J Cataract Refract Surg Date: 2000-03 Impact factor: 3.351
Authors: Irene C Kuo; Terrence P O'Brien; Aimee T Broman; Mehdi Ghajarnia; Nada S Jabbur Journal: J Cataract Refract Surg Date: 2005-11 Impact factor: 3.351
Authors: Peter Kim; Esther M Briganti; Gerard L Sutton; Michael A Lawless; Christopher M Rogers; Chris Hodge Journal: J Cataract Refract Surg Date: 2005-05 Impact factor: 3.351
Authors: David F Chang; Samuel Masket; Kevin M Miller; Rosa Braga-Mele; Brian C Little; Nick Mamalis; Thomas A Oetting; Mark Packer Journal: J Cataract Refract Surg Date: 2009-08 Impact factor: 3.351